Start Time: 16:30 January 1, 0000 5:11 PM ET
HeartBeam, Inc. (NASDAQ:BEAT)
Q4 2023 Earnings Conference Call
March 20, 2024, 16:30 PM ET
Company Participants
Branislav Vajdic - CEO and Founder
Rob Eno - President
Deborah Castillo - VP of Regulatory Affairs
Rick Brounstein - Consulting CFO
Conference Call Participants
Ben Haynor - Alliance Global Partners
Operator
Greetings, and welcome to the HeartBeam Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to differ materially.
You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events.
Throughout today's discussion, we will attend to present some important factors relating to our business that may affect our predictions. You should also review our most recent Form 10-K and Form 10-Q for a more complete discussion of these factors and other risks, particularly under the heading Risk Factors. A press release detailing these results crossed the wires this afternoon and is available in the Investor Relations section of our company's website, heartbeam.com.
Your host today, Branislav Vajdic, Chief Executive Officer and Founder; Rob Eno, President; Deborah Castillo, Vice President of Regulatory Affairs; and Rick Brounstein, Consulting Chief Financial Officer will present results of operations for the fourth quarter and full year ended December 31, 2023.
At this time, I will turn the call over to HeartBeam's Chief Executive Officer, Branislav Vajdic.
Branislav Vajdic
Thank you, operator. I'd like to start by giving a brief overview of HeartBeam and our technology. It is really important to understand how our VECG technology is different and lastly, more powerful than the most common personal ECG technologies that are out there in the marketplace today. A 12-lead ECG is one of the most commonly performed diagnostic tests, and it is actually a standard in hospitals and clinics. There are many ECG technologies that can be used by patients or consumers at home. You can see a couple of examples on this slide.